Medicare Enrolled

Dr. John Griffin, MD

Internal Medicine · Texarkana, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5002 COWHORN CREEK RD, Texarkana, TX 75503
9036143000
In practice since 2005 (20 years)
NPI: 1720088636 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Griffin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Griffin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Griffin

Dr. John Griffin is an internal medicine specialist in Texarkana, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Griffin performed 16,218 Medicare services across 7,172 unique beneficiaries.

Between the years covered by Open Payments, Dr. Griffin received a total of $3,185 from 33 pharmaceutical and/or device companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Griffin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in TX $3,185 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,218
Medicare services
Top 2% in TX for internal medicine
7,172
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~811 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 4,140 $18 $25
Blood draw (venipuncture) 1,388 $8 $20
Comprehensive metabolic blood panel 1,179 $10 $105
Urinalysis with microscopic exam 1,150 $3 $28
Office visit, established patient (30-39 min) 1,130 $79 $245
Lipid panel (cholesterol and triglycerides) 1,001 $13 $90
Complete blood count (CBC) with differential 959 $8 $48
Thyroid stimulating hormone (TSH) test 815 $16 $86
Hemoglobin A1c test (diabetes monitoring) 526 $9 $61
Urine microalbumin test (kidney screening) 509 $6 $59
Office visit, established patient (20-29 min) 383 $57 $175
Free thyroxine (T4) test 340 $9 $52
Urine culture, bacterial identification 202 $8 $42
Flu vaccine administration 161 $30 $35
Flu vaccine, high-dose 160 $72 $76
Annual wellness visit, follow-up 160 $125 $220
Drug injection, under skin or into muscle 158 $10 $42
Steroid injection (triamcinolone) 124 $1 $7
Antibiotic sensitivity test 117 $8 $58
Bacterial culture, aerobic 116 $8 $40
EKG interpretation and report 105 $6 $38
Administration of vaccine 102 $13 $48
Prostate cancer screening; prostate specific antigen test (psa) 92 $19 $79
Basic metabolic blood panel 83 $8 $88
Electrocardiogram (EKG), 12-lead 80 $10 $76
Chest X-ray, 2 views 69 $14 $44
Prothrombin time test (blood clotting) 62 $4 $26
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a 62 $27 $110
Vitamin B-12 level test 61 $15 $70
Injection, zoledronic acid, 1 mg 60 $7 $61
Sed rate test (inflammation marker) 58 $3 $26
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and 58 $37 $155
Dexamethasone injection (steroid) 52 $0 $2
C-reactive protein test (inflammation marker) 32 $5 $23
Transitional care management services for problem of at least moderate complexity 31 $158 $280
Lipase (fat enzyme) level 30 $7 $34
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow 27 $67 $200
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 25 $45 $58
Vitamin D level test 24 $29 $250
Transitional care management services for problem of high complexity 24 $215 $395
Folic acid level test 23 $14 $79
Pneumonia vaccine administration 23 $30 $45
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 23 $161 $325
Measurement of antibody for rheumatoid arthritis assessment 22 $13 $100
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 20 $47 $168
Iron level test 19 $6 $39
Transferrin (iron binding protein) level 19 $12 $50
Red blood count, automated test 19 $4 $25
Ferritin level test (iron stores) 18 $13 $52
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use 17 $281 $325
Shoulder X-ray, 2+ views 16 $16 $61
Knee X-ray, 3 views 16 $19 $66
Creatine kinase (cardiac enzyme) level, total 16 $6 $29
PSA test (prostate cancer screening) 15 $18 $79
Uric acid level test 14 $4 $24
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza 13 $53 $100
Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) 12 $12 $50
Detection test by immunoassay technique for other organism 12 $12 $34
Administration of vaccine, each additional vaccine 12 $11 $25
Office visit, established patient (10-19 min) 12 $36 $110
Thyroxine (thyroid chemical), total 11 $7 $40
Electrocardiogram (ecg) 2-day continuous with review by health care professional 11 $13 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
28.0% medium
71.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,185
Total received (2018-2024)
Avg $455/year across 7 years
Top 23% in TX for internal medicine
33
Companies
178
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,185 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$663
2023
$675
2022
$449
2021
$429
2020
$64
2019
$347
2018
$559

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$532
Janssen Pharmaceuticals, Inc
$440
Novartis Pharmaceuticals Corporation
$309
PFIZER INC.
$207
MIMEDX Group, Inc.
$179
AbbVie Inc.
$147
ABBVIE INC.
$126
Allergan Inc.
$124
E.R. Squibb & Sons, L.L.C.
$123
GlaxoSmithKline, LLC.
$121
Abbott Laboratories
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Lilly USA, LLC
$79
Dexcom, Inc.
$77
SANOFI-AVENTIS U.S. LLC
$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
Amarin Pharma Inc.
$45
Alnylam Pharmaceuticals Inc.
$41
Novo Nordisk Inc
$40
Allergan, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$31
Arbor Pharmaceuticals, Inc.
$28
Merck Sharp & Dohme Corporation
$26
Boston Scientific Corporation
$21
Almatica Pharma LLC
$21
Sanofi Pasteur Inc.
$19
Eisai Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Merck Sharp & Dohme LLC
$14
Astellas Pharma US Inc
$14
Horizon Therapeutics plc
$14
SANOFI PASTEUR INC.
$12
Agios Pharmaceuticals, Inc.
$12
Top 3 companies account for 40.2% of total payments
Associated products mentioned in payments ›
Aimovig · Amitiza · BELSOMRA · BYSTOLIC · CAMZYOS · CHANTIX · DIFICID · DUEXIS · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GLYXAMBI · GRALISE · JARDIANCE · LEQVIO · LINZESS · Leqembi · ONPATTRO · Otezla · Ozempic · PREVNAR 20 · PYRUKYND · Prolia · QULIPTA · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · TOUJEO · TRULICITY · Trintellix · UBRELVY · VIAGRA · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN FLX · XARELTO · XIFAXAN · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $20 per 100 Medicare services performed
Looking for an internal medicine specialist in Texarkana?
Compare internal medicine physicians in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
40
Per 100K population
43.3
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Griffin is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Griffin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Griffin performed 4,140 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Griffin receive payments from pharmaceutical companies?
Yes. Dr. Griffin received a total of $3,185 from 33 companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Griffin's costs compare to other internal medicine physicians in Texarkana?
Dr. Griffin's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Griffin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →